The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Buyanovskaya O.A.

National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov

The Joy of Motherhood

Authors:

Buyanovskaya O.A.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2026;(3): 22‑27

Read: 110 times

Buy for 300₽
Contact the author
Table of contents

To cite this article:

Buyanovskaya OA. The Joy of Motherhood. Non Nocere. New Therapeutic Journal. 2026;(3):22‑27. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Abstract:

Possibilities of Preserving Fertility in Women with Hereditary Tumor Syndrome.

Authors:

Buyanovskaya O.A.

National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov

Close metadata

References:

  1. Clinical recommendations AOR / Ovarian cancer / fallopian tube cancer / primary peritoneal cancer: rubricator of clinical recommendations / Ministry of Health of the Russian Federation. – Electron. Dan. – 2024. – ID: 547_3 (date of access: 01/15/2026). https://cr.minzdrav.gov.ru/view-cr/547_3
  2. Clinical recommendations AOR/Cancer of the uterine body and uterine sarcoma: rubricator of clinical recommendations / Ministry of Health of the Russian Federation. - Electron. Dan. – 2024. – ID: 460_4 (date of access: 01/15/2026). https://cr.minzdrav.gov.ru/view-cr/460_4
  3. Breast cancer: rubricator of clinical recommendations / Ministry of Health of the Russian Federation. - Electron. Dan. – 2021. – ID: 379_4 (date of access: 01/15/20256). https://cr.minzdrav.gov.ru/view-cr/379_4
  4. Recommendations from RSOM for the diagnosis and treatment of hereditary breast cancer / Russian Society of OncoMammologists (RSOM). – Electron. Dan. – 2014 (date of access: 01/15/2026). http://breastcancersociety.ru/download/599
  5. Daly MB, Pal T, Maxwell KN, et al. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024. J Natl Compr Canc Netw. 2023 Oct;21(10):1000-1010. https://doi.org/10.6004/jnccn.2023.0051
  6. Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA. 2017 Jun 20;317(23):2402-2416. https://doi.org/10.1001/jama.2017.7112
  7. Lambertini M, Ameye L, Hamy AS, et al. Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations. J Clin Oncol. 2020 Sep 10;38(26):3012-3023. https://doi.org/10.1200/JCO.19.02399
  8. Maksimenko J, Irmejs A, Gardovskis J. Pregnancy after breast cancer in BRCA1/2 mutation carriers. Hered Cancer Clin Pract. 2022 Jan 21;20(1):3.  https://doi.org/10.1186/s13053-022-00209-1
  9. Oktay KH, Bedoschi G, Goldfarb SB, et al. Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency. Fertil Steril. 2020 Jun;113(6):1251-1260.e1.  https://doi.org/10.1016/j.fertnstert.2020.01.033
  10. Lambertini M, Goldrat O, Ferreira AR, et al. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients. Ann Oncol. 2018 Jan 1;29(1):237-243.  https://doi.org/10.1093/annonc/mdx639
  11. Turan V, Lambertini M, Lee DY, et al. Association of Germline BRCA Pathogenic Variants With Diminished Ovarian Reserve: A Meta-Analysis of Individual Patient-Level Data. J Clin Oncol. 2021 Jun 20;39(18):2016-2024. https://doi.org/10.1200/JCO.20.02880
  12. Lambertini M, Blondeaux E, Agostinetto E, et al. Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study. JAMA. 2024 Jan 2;331(1):49-59.  https://doi.org/10.1001/jama.2023.25463
  13. Dossus L, Allen N, Kaaks R, et al. Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2010 Jul 15;127(2):442-451.  https://doi.org/10.1002/ijc.25050
  14. Condorelli M, Bruzzone M, Ceppi M, et al. Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer. ESMO Open. 2021 Dec;6(6):100300. https://doi.org/10.1016/j.esmoop.2021.100300
  15. Van Bommel MHD, IntHout J, Veldmate G, et al. Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers: a systematic review and meta-analysis. Hum Reprod Update. 2023 Mar 1;29(2):197-217.  https://doi.org/10.1093/humupd/dmac038
  16. Kotsopoulos J. Oral Contraceptives and BRCA Cancer: A Balancing Act. J Natl Cancer Inst. 2022 Apr 11;114(4):483-484.  https://doi.org/10.1093/jnci/djac006
  17. Kotsopoulos J, Gronwald J, Karlan BY, et al. Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers. JAMA Oncol. 2018 Aug 1;4(8):1059-1065. https://doi.org/10.1001/jamaoncol.2018.0211
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.